Active — Not RecruitingNot Applicable

Three-Axis Wearable Adaptive Vestibular Stimulator

United States40 participantsStarted 2023-11-15

Plain-language summary

The purpose of this study is to improve current galvanic vestibular stimulation (GVS) technology to ease the motion sickness often associated with virtual reality (VR) simulation.

Who can participate

Age range21 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * For our purposes, participants must be able to consent to participate themselves and be 21 to 55 years of age * Must be able to attend in-person sessions at the Mayo Aerospace Medicine and Vestibular Research Laboratory in Scottsdale, AZ. * No racial/ethnic groups will be excluded, although all participants must be fluent speakers of English. Exclusion Criteria: \- History of vestibular disease, migraine, or significant balance disorder; history of severe motion sensitivity, women who are pregnant.

What they're measuring

Pensacola Diagnostic Index-based motion sickness questionnaire

Timeframe: Immediately after each flight stimulation session, approximately 1 hour

COG Sway velocity

Timeframe: Immediately after balance testing in each session, approximately 1 hour

Trial details

NCT IDNCT06106256

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-10

View on ClinicalTrials.gov More Motion Sickness trials